Acro Biomedical Co., Ltd.
ACBM
$0.03
$0.0017.12%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 154.00K | 147.10K | 41.10K | 36.60K | 38.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 154.00K | 147.10K | 41.10K | 36.60K | 38.00K |
| Operating Income | -154.00K | -147.10K | -41.10K | -36.60K | -38.00K |
| Income Before Tax | -101.20K | -154.40K | -46.80K | -41.30K | -42.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.10 | -0.15 | -0.05 | -0.04 | -0.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.20K | -154.40K | -46.80K | -41.30K | -42.30K |
| EBIT | -154.00K | -147.10K | -41.10K | -36.60K | -38.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 240.17M | 240.17M | 240.17M | 240.17M | 240.17M |
| Average Diluted Shares Outstanding | 240.17M | 240.17M | 240.17M | 240.17M | 240.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |